DLD Asset Management »

Biomarin Pharma Inc convertible/ shares owned by DLD Asset Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.9M 5.0M 0.99

More positions owned by DLD Asset Management

Bloomin Brands Note 5.000% 5/0 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Livent Corp Note 4.125% 7/1 (Principal)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)
Wayfair Cl A Put Option (W)
Veradigm Note 0.875% 1/0 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Varex Imaging Corp Note 4.000% 6/0 (Principal)
Cinemark Hldgs Note 4.500% 8/1 (Principal)

View all positions for DLD Asset Management

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Partner Fund Management
Bank of America Corporation
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
MacKay Shields
Palisade Capital Management
Man Group
Royal Bank of Canada

View all funds holding Biomarin Pharma Inc convertible/